Next generation opto-gpcrs for neuromodulatory control

Active Cooperative Agreement Awarded Last action

Award ID
U01NS128537
Recipient
Awarding agency
Obligated
$10,205,337

Award facts

Completion date 95% complete
Place of performance
Seattle, WA 98195, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
The field of optogenetics - utilizing light to engage biological systems - is widely used for the dissection of neural circuits, cellular signaling and manipulating neurophysiological systems in awake, behaving animals. However, while many new opsins have been developed and are actively used, challenges still remain, and the current technology lacks a full toolbox for sub-cellular, spatiotemporal control of signaling - the predominant means for neuromodulator communication in the brain. Here we propose, an innovative effort combining neuroscience with structural biology and high-throughput pharmacology for the development of a series of cutting-edge novel opto-gpcrs that will allow spatiotemporally precise and pathway-selective control of neuromodulator signaling in vitro and in freely moving animals. In four aims across five leading laboratories, we will develop and test these novel tools in vitro and in vivo. Specifically, we will work to 1) develop and fully optimize optogpcr-V3.0 (GI coupled) receptors for enhanced spectral multiplexing and altered sensitivity using structure-function analysis together with mutant-library HTS landing pad system; 2) develop and fully optimize optogpcr-V3.0-GQ receptors for selective coupling to GQ signaling pathways using structure-guidance and the HTS landing pad system; 3) utilize databases of less-explored naturally-occurring opsin-gpcrs to test, screen and further develop new optical tools with unique profiles; and 4) assess the spectral compatibility for simultaneous use of optogpcr-V3.0 constructs in vivo, together with biosensors using photometry, 2P imaging and concurrent behavioral measures in vivo. Successful completion of the proposal will provide the wide neuroscience community with the long awaited capabilities of spatiotemporal manipulation of gpcr - neuromodulator signaling within neural circuits in vitro and in vivo, in awake freely behaving animals, and could be used for a wide variety of applications. This new technology will also further widen the field for unique optical approaches that allow discrete control and optodynamic simulation of neuromodulator function in brain tissue. We therefore believe that by the fulfilment of these goals we directly address the central purpose of this RFA-NS-21-027 call.

Transactions

Action Obligated Date
Amendment $331,833
Amendment $717,923
Amendment -$117,308
Amendment $117,307
Amendment $1,055,762
Amendment $1,055,762
Amendment $1,063,843
Amendment $1,063,843
Amendment $0
Amendment $0
Amendment $1,229,093
Amendment $1,229,093
Amendment $1,229,093
Original award $1,229,093
Show all 14

Subawards

Subrecipient Amount Awarded
Weizmann Institute Of Science Next Generation OptoGPCRs for Neuromodulatory Control. $366,463
The Washington University Next Generation Opto-GPCRs for Neuromodulatory Control. $164,526
The Washington University $201,457
Weizmann Institute Of Science $366,593

Quick answers

Who received award U01NS128537?

U01NS128537 was awarded to University Of Washington by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on January 15, 2023.

How much is award U01NS128537 worth?

$10,205,337 has been obligated on U01NS128537.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login